OspreyBio Completes Development of the Bird of Prey platform, Greatly Simplifying Building of Complex Multigenic Vectors
By
Lilith Saylor
|
Osprey BioScience, LLC, a gene and cell therapy biotools company and subsidiary of privately-held BioSolution Designs (www.biodzn.com) plans to unveil Bird of Prey at the 27th annual meeting of the American Society of Gene & Cell Therapy (ASGCT), the nation’s premier venue for new developments in gene therapy technologies and therapies. Bird of Prey, developed … Read more
BioSolution Designs Announces Formation of BeatBio Subsidiary to Develop Complex Multigenic Cardiovascular Therapies
By
Lilith Saylor
|
BioSolution Designs is pleased to announce the formation of its first drug development subsidiary, BeatBio, created to develop complex multigenic therapeutics for cardiovascular diseases. The company, headquartered in Cincinnati, is led by Thomas D Reed, PhD, who previously co-developed a multigenic plasmid DNA (pDNA) gene therapy (INXN-4001) at Triple-Gene, a cardiovascular gene therapy subsidiary of … Read more
BioSolution Designs and RoosterBio Announce Collaboration on Genetically Modified MSCs for Biotherapeutic Development
Community Collaboration
By
Lilith Saylor
|
BioSolution Designs (BSD), a biotechnology invention studio developing proprietary platforms for multigenic gene and cell therapies, today announced its ongoing strategic collaboration with RoosterBio, a leading provider of human mesenchymal stem/stromal cells (MSCs), highly engineered media solutions, and bioprocess development services. This partnership leverages BSD’s multigenic design and assembly platform, Bird of PreyTM, and cell … Read more
BioSolution Designs Announces New Management Team Member
By
Lilith Saylor
|
BioSolution Designs is pleased to announce that Shruti Abbato has joined the company as Chief Development Officer. Shruti brings two decades of biopharmaceutical corporate development expertise across biologics and gene and cell therapies, and complements the current team’s deep genetic engineering, operations, and bioinformatics expertise. BioSolution Designs (BSD) was founded in 2020 to invent currently … Read more
Thin Film Interconnects (TFI) Advances Stateside Chip Manufacturing
By
|
Frederick, Maryland – Thin Film Interconnects (TFI), a pioneering technology company, is poised to transform the high-demand semiconductor industry with its innovative manufacturing process. This established Korean firm will launch its inaugural U.S. operation with a patented, next-generation production process that surpasses current alternatives in speed and reduced environmental impact. TFI’s new 3DIC (three-dimensional integrated … Read more
FITCI & Living Well Youth Works Partner to Empower Youth Entrepreneurship & Career Exposure
By
|
Frederick, MD – Frederick Innovative Technology Center, Inc. (FITCI) and fellow nonprofit Living Well Youth Works proudly announce a strategic partnership to open new doors for school-aged children by putting them in front of life-enriching opportunities and experiences, such as building essential life and career skills, mining internship prospects, and connecting to higher education resources. … Read more
Frederick Innovative Technology Center, Inc. Congratulates 15 Companies Graduating The Edge Accelerator
By
|
Frederick Innovative Technology Center, Inc. Congratulates 15 Companies Graduating The Edge Accelerator The Edge Accelerator Demo Day on March 4 was the culmination of an immersive 12-week program. Frederick, MD (March 7, 2024): Some of Frederick’s most promising startup entrepreneurs took the stage in front of an esteemed panel of judges for the Frederick Innovative Technology Center, … Read more
NanoBioFAB nominated for two ICON 2024 Awards
By
|
Maryland Tech Council Announces 2024 ICON Awards Finalists Current FITCI client NanoBioFAB earned a spot in two categories of the The Maryland Tech Council’s (MTC) 2024 awards. MTC, the largest technology and life sciences trade association in the state and a FITCI ecosystem member, announced the finalists for its 2024 ICON Awards, which honor the … Read more
Mesa Science Associates Contributes to Study Demonstrating Efficacy of Intranasal Spray at Treating Anaphylaxis
By
|
FREDERICK, MD —Kenneth Dretchen, PhD, of Mesa Science Associates, in collaboration with researchers from Bryn Pharma LLC, Celerion Inc., and Allucent, recently published an article in the Journal of Allergy and Clinical Immunology: Global entitled “A 13.2 mg epinephrine intranasal spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to a 0.3 mg epinephrine autoinjector.” The current treatment option … Read more
